Table 1.
Anthropometric and biochemical parameters of the study subjects. The study participants were divided into two groups of LDL-C concentration, as follows: subjects with optimal concentration of LDL-C ≤ 100 mg/dL, and individuals with high concentration of LDL-C > 100 mg/dL. Total cholesterol and Castelli’s atherogenic risk index significantly increased in patients with LDL-C greater than 100 mg/dL. Abbreviations: F, female; M, male; BMI, body mass index; LDL-C, low-density lipoproteins; HDL-C, high-density lipoproteins; HOMA-IR, homeostatic model assessment of insulin resistance; CRP, C-reactive protein; a.u., arbitrary units. Data are presented as mean ± standard deviation. Differences were considered significant when p < 0.05.
| LDL-C | |||
|---|---|---|---|
| <100 mg/dL | >100 mg/dL | p-Value | |
| Sex (F/M) | 28/37 | 41/44 | 0.2650 |
| Age (years) | 47.2 ± 1.056 | 49.49 ± 1.031 | 0.1913 |
| BMI (kg/m2) | 28.22 ± 1.172 | 28.05 ± 0.9035 | 0.9155 |
| Waist circumference (cm) | 91.58 ± 2.94 | 96.73 ± 2.002 | 0.1696 |
| Body fat (%) | 31.87 ± 1.696 | 31.91 ± 2.614 | 0.9909 |
| Cholesterol (mg/dL) | 166.7 ± 7.079 | 220.7 ± 4.723 | <0.0001 |
| Triglycerides (mg/dL) | 242.6 ± 41.08 | 186.4 ± 11.14 | 0.0769 |
| LDL-C (mg/dL) | 76.53 ± 4.156 | 128.7 ± 3.653 | <0.0001 |
| HDL-C (mg/dL) | 42.13 ± 3.44 | 47.06 ± 2.226 | 0.2332 |
| Insulin (µU/L) | 14.43 ± 1.057 | 13.52 ± 0.8046 | 0.5208 |
| Glucose (mmol/L) | 5.104 ± 0.2653 | 5.346 ± 0.2502 | 0.5675 |
| HOMA-IR (a.u.) | 3.299 ± 0.3261 | 3.126 ± 0.1866 | 0.6290 |
| CRP (mg/L) | 5.095 ± 0.4755 | 5.012 ± 0.6004 | 0.6328 |
| Castelli’s risk index II | 1.966 ± 0.1827 | 2.892 ± 0.1294 | 0.0002 |